The Original Human-on-a-Chip Company

Pioneers for Reducing Animal Testing through Emulating Biology

the leading light for human-on-a-chip Research

Hesperos is named for Venus in the evening sky. Like her, we are a leading light, providing world-class research in disease modeling and drug testing through our use of human-on-a-chip systems. Our patent positions and the over 20 years of expertise of both Drs. Shuler and Hickman make us the company to work with for your most difficult problems as well as for cost competitive, routine, human-on-a-chip assays.

The hesperos difference

Hesperos, Inc. brings together biologists, surface chemists, and engineers in order to produce some of the worlds most advanced organs-on-chips. From gene expression to electrophysiology, our biologists recreate key components of various organs. Chemically patterned microchips are engineered to enable real-time monitoring of organ activity. Finally, our engineers utilize sophisticated measurement techniques in order to detect and quantify minute changes.  The result of this collaboration is an ability to study therapeutics in a way which was previously only possible in clinical trials.

As Featured In

Industries We Serve

Rare Disease

Pharmacology

Chemicals, Nutraceuticals, and Supplements

Hesperos’ Models Under Consideration to Address Opiod Crisis

By Hesperos | March 18, 2019 | 0 Comments

The interest in our human-on-a-chip model continues to grow.  Last week we brought our systems to the National Center for Translational Science (NCATS) at the NIH in Washington, D.C. to perform a real-time demo using live … Read More

Mice no more? Hesperos’ multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicology Testing

By Hesperos | March 1, 2019 | 0 Comments

Collaboration between L’Oreal, Hesperos and UCF results in further reduction in reliance on animal testing in drug and cosmetics development (ORLANDO, Fla.) The replacement of animals as test subjects is one step closer to reality with … Read More

Hesperos at NCATS-NASA State-of-the-Science Meeting

By Hesperos | January 2, 2019 | 0 Comments

We’ve been forging new frontiers with our human-on-a-chip multi-organ models—could the next one take us into space?  Last month, we traveled to Washington, DC, to attend a workshop with officials from NASA,NCATS (National Center for Advancing … Read More

Spotlight on Hesperos Innovation at Florida Life Sciences Conference

By Hesperos | October 17, 2018 | 0 Comments

We were proud to join hundreds of Florida’s executives, scientists, researchers, investors, legislators, and service providers from the biopharmaceutical, medical device, and healthIT at the recent BioFlorida Annual Conference to celebrate Florida innovation and achievements — … Read More

Hesperos, Inc. Among GROWFL 2018 Florida Companies to Watch

By Hesperos | September 20, 2018 | 0 Comments

(ORLANDO, Fla.)  Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more … Read More

About Our Team

Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems which they coined "human-on-a-chip."

Simulating Organ Function

Unlike other tests that extrapolate organ function based on biomarker activity and protein analysis, our models are working systems that recreate muscle and tissue function as well as neural and inter-organ communication. The resulting functional reports closely correlate to what clinicians observe in human clinical trials.

Data Driven Analysis

Our systems generate thousands of data points which correlate to key functional aspects of each organ.  Our custom analyses are then able to parse the data quickly and fruitfully to identify subtle changes in function alongside large-scale shifts in morphology and behavior, yielding insights into each drug.

Interested in working with hesperos?